If this scenario exists in human KS tumors, downregulation of GLUT1 and GLUT3, and suppression of aerobic glycolysis should be readily present regardless of the status of acute or persistent infection in the tumors. The gene discussed is SLC2A1; the disease is Kaposi's sarcoma.